- Home
- OIA vs SOPH Comparison
OIA vs SOPH Comparison
Compare OIA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIA
- SOPH
- Stock Information
- Founded
- OIA 1988
- SOPH 2011
- Country
- OIA United States
- SOPH Switzerland
- Employees
- OIA N/A
- SOPH N/A
- Industry
- OIA Finance Companies
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OIA Finance
- SOPH Health Care
- Exchange
- OIA Nasdaq
- SOPH Nasdaq
- Market Cap
- OIA 329.3M
- SOPH 247.0M
- IPO Year
- OIA N/A
- SOPH 2021
- Fundamental
- Price
- OIA $6.75
- SOPH $3.40
- Analyst Decision
- OIA
- SOPH Strong Buy
- Analyst Count
- OIA 0
- SOPH 3
- Target Price
- OIA N/A
- SOPH $7.00
- AVG Volume (30 Days)
- OIA 97.9K
- SOPH 21.9K
- Earning Date
- OIA 01-01-0001
- SOPH 11-05-2024
- Dividend Yield
- OIA 4.88%
- SOPH N/A
- EPS Growth
- OIA N/A
- SOPH N/A
- EPS
- OIA N/A
- SOPH N/A
- Revenue
- OIA N/A
- SOPH $64,938,000.00
- Revenue This Year
- OIA N/A
- SOPH $7.70
- Revenue Next Year
- OIA N/A
- SOPH $20.61
- P/E Ratio
- OIA N/A
- SOPH N/A
- Revenue Growth
- OIA N/A
- SOPH 20.14
- 52 Week Low
- OIA $4.93
- SOPH $2.70
- 52 Week High
- OIA $6.72
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- OIA 46.73
- SOPH 44.10
- Support Level
- OIA $6.73
- SOPH $3.22
- Resistance Level
- OIA $6.98
- SOPH $3.66
- Average True Range (ATR)
- OIA 0.10
- SOPH 0.20
- MACD
- OIA -0.03
- SOPH 0.01
- Stochastic Oscillator
- OIA 3.85
- SOPH 58.60
About OIA Invesco Municipal Income Opportunities Trust
Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.